Position in TAK
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$5,044,432
+$828,984 QoQ
Shares Held
314,687
+38.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#43
of 375 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ASSETMARK, INC holds $375,029,634 across 23 Drug Manufacturers - Specialty & Generic names. TAK ranks #3 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
624,068 | $338,138,764 | |
| 2 | ZTS |
Zoetis Inc.
|
282,029 | $20,266,603 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
314,687 | $5,044,432 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
16,414 | $2,766,415 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
81,250 | $2,752,750 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
49,713 | $2,312,151 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
68,590 | $1,384,146 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
12,110 | $1,343,483 |
All Filings in TAK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,044,432 | 314,687 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $4,215,448 | 227,616 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,433,910 | 156,120 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,789,271 | 122,218 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,479,831 | 95,720 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,286,834 | 86,539 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,140,851 | 86,167 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,151,564 | 80,982 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $989,677 | 76,482 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,049,972 | 75,592 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,023,558 | 71,728 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,106,646 | 71,535 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,123,799 | 71,534 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,097,370 | 66,588 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $233,064 | 14,940 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $179,634 | 13,850 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $180,582 | 12,862 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $197,931 | 13,822 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $172,692 | 12,670 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $196,609 | 12,003 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $1,129,291 | 62,049 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $666,662 | 37,369 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $506,253 | 28,235 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $294,370 | 19,392 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||